Literature DB >> 28504192

Correlates of protection for enteric vaccines.

Jan Holmgren1, Umesh D Parashar2, Stanley Plotkin3, Jacques Louis4, Su-Peing Ng5, Eric Desauziers6, Valentina Picot7, Mitra Saadatian-Elahi8.   

Abstract

An immunological Correlate of Protection (CoP) is an immune response that is statistically interrelated with protection. Identification of CoPs for enteric vaccines would help design studies to improve vaccine performance of licensed vaccines in low income settings, and would facilitate the testing of future vaccines in development that might be more affordable. CoPs are lacking today for most existing and investigational enteric vaccines. In order to share the latest information on CoPs for enteric vaccines and to discuss novel approaches to correlate mucosal immune responses in humans with protection, the Foundation Mérieux organized an international conference of experts where potential CoPs for vaccines were examined using case-studies for both bacterial and viral enteric pathogens. Experts on the panel concluded that to date, all established enteric vaccine CoPs, such as those for hepatitis A, Vi typhoid and poliovirus vaccines, are based on serological immune responses even though these may poorly reflect the relevant gut immune responses or predict protective efficacy. Known CoPs for cholera, norovirus and rotavirus could be considered as acceptable for comparisons of similarly composed vaccines while more work is still needed to establish CoPs for the remaining enteric pathogens and their candidate vaccines. Novel approaches to correlate human mucosal immune responses with protection include the investigation of gut-originating antibody-secreting cells (ASCs), B memory cells and follicular helper T cells from samples of peripheral blood during their recirculation.
Copyright © 2017.

Entities:  

Keywords:  Conference; Correlates of protection; Enteric pathogens; Enteric vaccines

Mesh:

Substances:

Year:  2017        PMID: 28504192     DOI: 10.1016/j.vaccine.2017.05.005

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Cognate T and B cell interaction and association of follicular helper T cells with B cell responses in Vibrio cholerae O1 infected Bangladeshi adults.

Authors:  Rasheduzzaman Rashu; Taufiqur Rahman Bhuiyan; Mohammad Rubel Hoq; Lazina Hossain; Anik Paul; Ashraful Islam Khan; Fahima Chowdhury; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Ana A Weil; Firdausi Qadri
Journal:  Microbes Infect       Date:  2018-12-21       Impact factor: 2.700

2.  Human influenza virus challenge identifies cellular correlates of protection for oral vaccination.

Authors:  David R McIlwain; Han Chen; Zainab Rahil; Neda Hajiakhoond Bidoki; Sizun Jiang; Zach Bjornson; Nikita S Kolhatkar; C Josefina Martinez; Brice Gaudillière; Julien Hedou; Nilanjan Mukherjee; Christian M Schürch; Angelica Trejo; Melton Affrime; Bonnie Bock; Kenneth Kim; David Liebowitz; Nima Aghaeepour; Sean N Tucker; Garry P Nolan
Journal:  Cell Host Microbe       Date:  2021-11-15       Impact factor: 21.023

3.  Confronting challenges to enterotoxigenic Escherichia coli vaccine development.

Authors:  James M Fleckenstein
Journal:  Front Trop Dis       Date:  2021-09-24

4.  Contribution of Noncanonical Antigens to Virulence and Adaptive Immunity in Human Infection with Enterotoxigenic E. coli.

Authors:  F M Kuhlmann; R O Laine; S Afrin; R Nakajima; M Akhtar; T Vickers; K Parker; N N Nizam; V Grigura; C W Goss; P L Felgner; D A Rasko; F Qadri; J M Fleckenstein
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

Review 5.  Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access.

Authors:  Ibrahim Khalil; Richard Walker; Chad K Porter; Farzana Muhib; Roma Chilengi; Alejandro Cravioto; Richard Guerrant; Ann-Mari Svennerholm; Firdausi Qadri; Shahida Baqar; Margaret Kosek; Gagandeep Kang; Claudio Lanata; George Armah; Thomas Wierzba; Mateusz Hasso-Agopsowicz; Birgitte Giersing; A Louis Bourgeois
Journal:  Vaccine       Date:  2021-05-06       Impact factor: 3.641

6.  Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection.

Authors:  Bolutife Fakoya; Karthik Hullahalli; Daniel H F Rubin; Deborah R Leitner; Roma Chilengi; David A Sack; Matthew K Waldor
Journal:  mBio       Date:  2022-04-07       Impact factor: 7.786

7.  Activated T follicular helper-like cells are released into blood after oral vaccination and correlate with vaccine specific mucosal B-cell memory.

Authors:  Ana Cárdeno; Maria K Magnusson; Marianne Quiding-Järbrink; Anna Lundgren
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

8.  Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection.

Authors:  Subhra Chakraborty; Arlo Randall; Tim J Vickers; Doug Molina; Clayton D Harro; Barbara DeNearing; Jessica Brubaker; David A Sack; A Louis Bourgeois; Philip L Felgner; Xiaowu Liang; Sachin Mani; Heather Wenzel; R Reid Townsend; Petra E Gilmore; Michael J Darsley; David A Rasko; James M Fleckenstein
Journal:  NPJ Vaccines       Date:  2019-08-28       Impact factor: 7.344

9.  An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses.

Authors:  Stephanie Longet; Aine Abautret-Daly; Sukanya Raghavan; Ed C Lavelle; Christopher J H Davitt; Craig P McEntee; Vincenzo Aversa; Monica Rosa; Ivan S Coulter; Jan Holmgren
Journal:  NPJ Vaccines       Date:  2019-10-25       Impact factor: 7.344

10.  An integrative docking and simulation-based approach towards the development of epitope-based vaccine against enterotoxigenic Escherichia coli.

Authors:  Fariya Khan; Ajay Kumar
Journal:  Netw Model Anal Health Inform Bioinform       Date:  2021-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.